REFERENCES
- Preskorn S. H. Pharmacokinetics of Antidepressant: Why and How They Are Relevant to Treatment. J. Clin. Psychiat. 1993; 54: 14–34
- Biederman J. Sudden Death in Children Treated with Tricyclic Antidepressant. J. Am. Acad. Child Adolesc. Psychiat. 1993; 30: 495–498
- Boehnert M. T., Lovejoy F. H. Value of the QRS Duration Versus the Serum Drug Level in Predicting Seizures and Ventricular Arrhythmias After and Acute Overdose of Tricyclic Antidepressants. N. Engl. J. Med. 1985; 313: 474–479
- Baselt R. C. Disposition of Toxic Drugs and Chemicals in Man. 5th Ed., Chemical Toxicology Institute, Foster City, CA 2000; 919
- Apple F. S. Postmortem Tricyclic Antidepressant Concentrations: Assessing Cause of Death Using Parent Drug to Metabolic Ratio. J. Anal. Tox. 1989; 13: 197–198
- Apple F. S., Bandt C. M. Liver and Blood Postmortem Tricyclic Antidepressant Concentrations. Am. J. Clin. Path. 1989; 89: 794–796
- Marti V., Ballester M., Udina C., Carrio I., Alvarez E., Obrador D., Pons-Llado G. Evaluation of Myocardial Cell Damage by In-111-Monoclonal Antimyosin Antibodies in Patients Under Chronic Tricyclic Antidepressant Drug Treatment. Circulation 1995; 91: 1619–1673